[1]
“Treatment Outcomes of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Co-Transporter-2 Inhibitors in Diabetes Mellitus with Poor Glycemic Control”, J. Medicine, vol. 25, no. 2, pp. 107–114, Jul. 2024, doi: 10.3329/jom.v25i2.74306.